Simona Mercogliano
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Study protocol on quality of life and erectile function recovery in unfavorable intermediate-risk prostate cancer: REDI-CaP trial.
Journal: Future oncology (London, England)
Published: August 27, 2026
Breast cancer radiotherapy in patients with autoimmune or cancer-associated myositis: balancing oncological benefit and immune-mediated risk.
Journal: Radiation oncology (London, England)
Published: May 28, 2026
Corrigendum to "Efficacy and Safety Outcomes of Stereotactic Radiotherapy with Cyberknife System in Brain Metastases patients treated with Immunotherapy (IO) or Targeted Therapy (TT)" [Clin Oncol 52C (2026) 104084].
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: May 07, 2026
First Results Comparing MLC Versus IRIS CyberKnife Collimators in Prostate Stereotactic Body Radiation Therapy in an Italian Oncology Institute.
Journal: Bioengineering (Basel, Switzerland)
Published: March 16, 2026
Optimizing Left-Sided Breast Cancer Radiotherapy: Strategy-Dependent Trade-Offs Among VMAT and Hybrid Techniques.
Journal: Cancer management and research
Published: December 23, 2025
Spatially fractionated radiation therapy for bulky tumors: a systematic review of clinical outcomes and dosimetric challenges.
Journal: Radiation oncology (London, England)
Published: December 19, 2025
Neoadjuvant ultrahypofractionated radiotherapy with simultaneous integrated boost for glioblastoma: study protocol for a phase I multicenter clinical trial.
Journal: BMC cancer
Published: October 27, 2025
Efficacy and Safety Outcomes of Stereotactic Radiotherapy With Cyberknife System in Brain Metastases Patients Treated With Immunotherapy or Targeted Therapy.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: January 27, 2025
Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial.
Journal: Frontiers in oncology
Published: July 31, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026